BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

CAPS Rating: 2 out of 5

A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.

Recs

2
Player Avatar rockfishcc8 (23.56) Submitted: 7/14/2009 2:59:59 PM : Underperform Start Price: $5.63 BDSI Score: -24.19

BDSI has been sucking investors in with their Onsolis diskettes for phentonyl.The date keeps moving back as the price continues to slide back to where it started.This isthe 2nd attempt by the same hedge fund to squeeze slowly the Onsolis approval rumor.I for one will not be had a second time with the same trick by the same hedge fund

Member Avatar acts20 (24.16) Submitted: 9/29/2011 9:12:51 PM
Recs: 0

You called it

Featured Broker Partners


Advertisement